Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apeloa Kangyu Pharmaceutical is a leading Chinese pharmaceutical manufacturer specializing in the production of Active Pharmaceutical Ingredients (APIs) and chemical intermediates. As a core subsidiary of the publicly traded Apeloa Pharmaceutical, the company operates large-scale manufacturing facilities that comply with international GMP standards, including certifications from the FDA and EDQM. Its product portfolio is heavily focused on anti-infectives, particularly penicillins and cephalosporins, as well as cardiovascular and central nervous system medications. Beyond generic API production, the company provides comprehensive CDMO services to global pharmaceutical partners, supporting projects from clinical development through to commercial supply. The company is headquartered in the Hengdian Industrial Zone of Zhejiang Province and plays a vital role in the global pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apeloa Kangyu Pharmaceutical.